Skip to main content
Mark Murakami, MD, Oncology, Boston, MA

Mark A Murakami MD

Hematologic Oncology


Fellow in Hematology/Oncology, Dana-Farber Cancer Institute/Massachusetts General Hospital

Join to View Full Profile
  • 450 Brookline AveDana-Farber Cancer Institute, Smith Building, Room 357Boston, MA 02215

  • Phone+1 617-632-3779

  • Fax+1 617-632-5822

Dr. Murakami is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2009 - 2012
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 2009

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2011 - 2026
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults
    Mark A. Murakami, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Signaling Input from Divergent Pathways Subverts Malignant B-Cell Transformation
    Mark A. Murakami, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • South Africa: Two International Awards for UCT's Katherine Antel
    South Africa: Two International Awards for UCT's Katherine AntelAugust 2nd, 2022
  • New Public Repository of Patient-Derived Cancer Models Aims to Improve Drug Testing
    New Public Repository of Patient-Derived Cancer Models Aims to Improve Drug TestingApril 11th, 2016

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: